Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001387131-12-000246
Filing Date
2012-02-10
Accepted
2012-02-10 13:46:04
Documents
3
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 AMENDED ANNUAL REPORT ohr_10ka-093011.htm 10-K/A 63802
2 302 CERTIFICATION OF THE CEO ex-31_1.htm EX-31.1 10739
3 302 CERTIFICATION OF THE CFO ex-31_2.htm EX-31.2 10699
  Complete submission text file 0001387131-12-000246.txt   86420
Mailing Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106
Business Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106 347-753-4389
Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)

EIN.: 133709558 | Fiscal Year End: 0930
Type: 10-K/A | Act: 34 | File No.: 333-88480 | Film No.: 12591646
SIC: 2834 Pharmaceutical Preparations